Landmark approval of the first CRISPR therapy paves the way for treatments based on more efficient and more precise genome editors. Landmark approval of the first CRISPR therapy paves the way for treatments based on more efficient and more precise genome editors.
Pioneering epigenome editing company Tune Therapeutics has announced it is working on a new and potentially curative approach to treating chronic HBV infection.
No pollen, no seeds - Innovations Report innovations-report.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from innovations-report.com Daily Mail and Mail on Sunday newspapers.